CJC-1295 is C152H252N44O42. It is soluble in water or 1% acetic acid at a concentration of ≥1mg/ml to give a clear,colorless solution
CJC-1295 is a long-acting version of GHRH (Growth Hormone Releasing Hormone) half life of 8 days. CJC-1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown potential to increase growth hormone and IGF-I secretion and effects, but it has been able to do so in very large amounts. GM2 Labs CJC-1295 peptide continuously elevates Growth Hormone (HGH) and IGF-1. The most noteworthy problem is the half life of the peptide, which has been shown to be ~7 minutes using advanced HPLC technologies that have proven to be very accurate. he trial was ultimately successful for most research subjects, but the drug's marketing stalled when three of the trial's patients suffered a myocardial infarction. The reason for this relatively short half life is due to an enzyme called dipeptidy lamino peptidase IV (DPP-IV), which has a high affinity for the amino acids Ala and Pro and in the case of GHRH it cleaves the 1 and 2 positions that consist of Tyr-Ala, creating GHRH3-29, an inactive form of the peptide.
CJC - 1295 Stimulates GH and IGF-1 Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis for more muscle growth.
More about: CJC-1295
Read more>> www.polypeptides.net